Katipunan, Genesis G.
HRN: 22-25-46 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/26/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
11/26/2022
12/03/2022
IV
600mg
Q6
Open Fracture 3A
Waiting Final Action
Indication: Empiric Type of Infection: Bone & Joint Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes